Vigil Neuroscience, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vigil Neuroscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
  • Vigil Neuroscience, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.7M, a 7.37% increase year-over-year.
  • Vigil Neuroscience, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$88.4M, a 5.42% decline year-over-year.
  • Vigil Neuroscience, Inc. annual Operating Income (Loss) for 2023 was -$88.9M, a 29% decline from 2022.
  • Vigil Neuroscience, Inc. annual Operating Income (Loss) for 2022 was -$68.9M, a 62.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$88.4M -$20.7M +$1.65M +7.37% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$90.1M -$22.5M -$565K -2.58% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$89.5M -$21.4M -$640K -3.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$88.9M -$23.9M -$4.98M -26.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$83.9M -$22.3M -$4.68M -26.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$79.2M -$21.9M -$4.87M -28.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$74.3M -$20.8M -$5.44M -35.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$68.9M -$18.9M -$5.9M -45.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$63M -$17.6M -$6.9M -64.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$56.1M -$17M -$6.27M -58.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$49.8M -$15.3M -$7.41M -93.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$42.4M -$13M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$10.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$10.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$7.92M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.